← Back to Home

Outlook Therapeutics

NASDAQ: OTLK ↗$0.68 USD~$200M MCAP

#Ophthalmology #Wet AMD #Biosimilars

Outlook Therapeutics is a ophthalmology company. See today's news for the latest developments.

Company Info

Sector:Ophthalmology

Headquarters:Princeton, New Jersey, USA

Founded:2010

Website:outlooktherapeutics.com/

Upcoming Milestones & Key Dates

2026-07-28

Milestone

Initial profile created

Clinical Development Pipeline

See pipeline

Target: See pipeline

See pipeline

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Recent News

Business & Strategy•Jul 27, 2026•Fierce Pharma

After 3 CRLs, FDA approves Outlook's AMD drug Lytenava ↗

After 3 CRLs, FDA approves Outlook's AMD drug Lytenava.

Leadership Team

See company website

Leadership team

Careers & Job Openings

See all open roles